Stanford University
Showing 1-10 of 413 Results
-
Elias Aboujaoude, MD, MA
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Aboujaoude is a Clinical Professor, researcher and writer at Stanford University's Department of Psychiatry, where he is Chief of the Anxiety Disorders Section and Director of the OCD Clinic and the Impulse Control Disorders Clinic. Besides the compulsivity-impulsivity spectrum, his work has focused on the intersection of technology and psychology, with an emphasis on the problematic use of Internet-related technologies, mental health in a post-privacy world, and the potential for telemedicine interventions such as virtual reality and video-based therapy to increase access to care and advance global health. His books include "Virtually You: The Dangerous Powers of the e-Personality" and "Mental Heath in the Digital Age: Grave Dangers, Great Promise". Dr. Aboujaoude also teaches psychology on the main Stanford campus and at UC Berkeley. Scholarly and media platforms that have featured his work include The New York Times, The Wall Street Journal, The Washington Post, Congressional Quarterly, The Harvard Business Review, The Chronicle of Higher Education, BBC, PBS, and CNN.
-
Connor Adams
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Connor Adams (she/they) is a Clinical Assistant Professor who received her doctorate in psychology from the George Washington University and completed her internship training at Harvard Medical School/Cambridge Health Alliance. Her clinical and research interests center on therapeutic interventions that support recovery for individuals living with serious mental illness. Dr. Adams grounds her work in a psychodynamic perspective, assisting individuals in understanding why they think, feel, and behave the way they do, in order to increase agency and choice. Dr. Adams has specialized training in comprehensive Dialectical Behavior Therapy and provides treatment for individuals with emotion regulation difficulties. She also has specialized training in Cognitive Behavioral Therapy for Psychosis (CBTp). Additionally, Dr. Adams provides individual and group psychotherapy within the psychiatric inpatient treatment setting. She is broadly interested in increasing access to person-centered and recovery-oriented care.
-
Sarah Adler
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am interested in the design and delivery of clinical care using, data and technology. I have focused on disordered eating behaviors and obesity.
-
Raag Airan
Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Materials Science & Engineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsOur goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.
-
Amy Alexander
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCollege Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians
-
Olivia Altamirano, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCulturally Sensitive Therapy is a group psychotherapy for people with early psychosis and their families. Study aims are to understand if this treatment is compatible with this population, to assess improvements in family functioning and mental health symptoms, to assess mediating factors (e.g., increased usage of adaptive religious and other cultural beliefs/values), and to assess longevity of improvements. Last, we aim to qualitatively understand participants’ experiences with this treatment.
